Ildong Holdings Co., Ltd. (KRX:000230)
6,570.00
-10.00 (-0.15%)
Feb 21, 2025, 9:00 AM KST
Ildong Holdings Revenue
Ildong Holdings had revenue of 166.57B KRW in the quarter ending September 30, 2024, with 4.07% growth. This brings the company's revenue in the last twelve months to 649.81B, up 1.33% year-over-year. In the year 2023, Ildong Holdings had annual revenue of 638.45B, down -5.49%.
Revenue (ttm)
649.81B
Revenue Growth
+1.33%
P/S Ratio
0.11
Revenue / Employee
8.12B
Employees
80
Market Cap
74.19B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 638.45B | -37.09B | -5.49% |
Dec 31, 2022 | 675.54B | 83.17B | 14.04% |
Dec 31, 2021 | 592.37B | -4.09B | -0.69% |
Dec 31, 2020 | 596.47B | 304.25B | 104.12% |
Dec 31, 2019 | 292.22B | 245.17B | 521.09% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 4,364.39B |
Celltrion | 2,876.25B |
Yuhan | 2,008.84B |
SK Biopharmaceuticals | 511.33B |
SK bioscience | 201.30B |
Hanmi Pharm. | 1,495.50B |
Peptron | 2.41B |
Hanall Biopharma | 134.24B |